• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Anna R. Docherty, PhD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Clinical Practice:

Dr. Docherty completed a Ph.D. in Clinical Psychology (2013) from the Department of Psychological Sciences at the University of Missouri-Columbia, a member of the Academy of Psychological Clinical Science. Prior to graduating, she completed advanced training at several sites: several clinical pre-practica and a clinical internship at the Minneapolis VA Medical Center (over 4000 assessment and intervention hours); clinical practica and an Assistant Directorship at the Columbia Psychological Services Clinic (over 2000 assessment and intervention hours); 250 hours of forensic and psychosis assessment and cognitive testing at the Fulton State Hospital, and over 300 hours of clinical and cognitive assessment at the Yale Psychiatric Institute and Connecticut Mental Health Center, including certification for the prodromal assessment of psychosis.

Dr. Docherty utilizes Acceptance and Commitment Therapy (ACT), Cognitive Behavioral Therapy (CBT), Prolonged Exposure (PE), Social Skills Training for schizophrenia (SST), group CBT/CBSST, multi-family psycho-education for schizophrenia, and behavioral family therapy (BFT). She specializes in differential diagnostic assessment and in individual and family therapy for the management of complex, severe mental health concerns. Dr. Docherty is a member of the Utah LGBTQIA+ Affirmative Therapists Guild and the Transgender Health Program at the University of Utah.

Research, Service, & Teaching:

Dr. Docherty was a predoctoral (NIMH F31) and postdoctoral (NIMH T32 & K01) NIMH research fellow, with awards to study quantitative genetics and bioinformatics before and after her clinical residency with the Minneapolis VA Healthcare System. This research led her to collaborate with the Wellcome Trust and the Psychiatric Genomics Consortium (PGC), and to lead projects examining molecular genetic risk in the context of behavioral health.

Since 2016, Dr. Docherty has directed a computational laboratory at HMHI to examine the genetics of suicide, treatment-resistant depression, and psychosis. The research team leverages large genetic datasets to study psychiatric populations, suicide deaths, and healthy emerging adults, as has secured funding from the NIMH, the Simons Foundation, the American Foundation for Suicide Prevention, and the Brain & Behavior Research Foundation to test models of genetic risk for major mental health conditions. Dr. Docherty's lab maintains a computational pipeline for genome-wide analysis and risk scoring of hundreds of mental and physical health outcomes (the “phenome”) to study the inter-relationships of psychiatric and medical conditions across critical stages of human development. Currently, Dr. Docherty’s focus is on enhancing prevention of severe psychopathology and suicide risk during emerging adulthood and in high-risk populations.

In addition to her statistical genetics research, Dr. Docherty is Chair of the Suicide Working Group of the Psychiatric Genomics Consortium (PGC), she serves on the PGC Steering Committee, and she is a contributing PI/analyst to several other working groups (MDD, Anxiety, Schizophrenia, PTSD, ADHD, SUD, LAGC, and Gen-ECT-ic). Dr. Docherty is also active in bioethics initiatives relating to pharmacogenomics and psychiatric genetic testing, and serves as Chair of the International Society for Psychiatric Genetics (ISPG) Ethics, Position, & Policy Advisory Committee. Dr. Docherty also serves on the Biomarker and Treatment-Resistant Depression working groups of the National Network of Depression Centers (NNDC). Locally, Dr. Docherty leads analyses of ketamine intervention outcomes at HMHI, and she is teaching faculty and Associate Course Director of HMHI’s annual NIH-funded R25 workshop, Advanced Statistical Training for Imaging and Genetics.

Specialties

  • Schizophrenia
  • Depression
  • Anxiety
  • Bipolar Disorder
  • Mood Disorders
  • Clinical Psychology
  • Psychology, Clinical
  • Psychiatric Genetics
  • Psychosis
  • Psychosis Prodrome
  • LGBTQ
  • Psychiatry
  • Psychology, Family
  • Survivorship/ Late Effects
  • Transgender Health

Board Certification and Academic Information

Academic Departments Psychiatry - Assistant Professor
Academic Divisions Adult Psychiatry

Clinical Practice:

Dr. Docherty completed a Ph.D. in Clinical Psychology (2013) from the Department of Psychological Sciences at the University of Missouri-Columbia, a member of the Academy of Psychological Clinical Science. Prior to graduating, she completed advanced training at several sites: several clinical pre-practica and a clinical internship at the Minneapolis VA Medical Center (over 4000 assessment and intervention hours); clinical practica and an Assistant Directorship at the Columbia Psychological Services Clinic (over 2000 assessment and intervention hours); 250 hours of forensic and psychosis assessment and cognitive testing at the Fulton State Hospital, and over 300 hours of clinical and cognitive assessment at the Yale Psychiatric Institute and Connecticut Mental Health Center, including certification for the prodromal assessment of psychosis.

Dr. Docherty utilizes Acceptance and Commitment Therapy (ACT), Cognitive Behavioral Therapy (CBT), Prolonged Exposure (PE), Social Skills Training for schizophrenia (SST), group CBT/CBSST, multi-family psycho-education for schizophrenia, and behavioral family therapy (BFT). She specializes in differential diagnostic assessment and in individual and family therapy for the management of complex, severe mental health concerns. Dr. Docherty is a member of the Utah LGBTQIA+ Affirmative Therapists Guild and the Transgender Health Program at the University of Utah.

Research, Service, & Teaching:

Dr. Docherty was a predoctoral (NIMH F31) and postdoctoral (NIMH T32 & K01) NIMH research fellow, with awards to study quantitative genetics and bioinformatics before and after her clinical residency with the Minneapolis VA Healthcare System. This research led her to collaborate with the Wellcome Trust and the Psychiatric Genomics Consortium (PGC), and to lead projects examining molecular genetic risk in the context of behavioral health.

Since 2016, Dr. Docherty has directed a computational laboratory at HMHI to examine the genetics of suicide, treatment-resistant depression, and psychosis. The research team leverages large genetic datasets to study psychiatric populations, suicide deaths, and healthy emerging adults, as has secured funding from the NIMH, the Simons Foundation, the American Foundation for Suicide Prevention, and the Brain & Behavior Research Foundation to test models of genetic risk for major mental health conditions. Dr. Docherty's lab maintains a computational pipeline for genome-wide analysis and risk scoring of hundreds of mental and physical health outcomes (the “phenome”) to study the inter-relationships of psychiatric and medical conditions across critical stages of human development. Currently, Dr. Docherty’s focus is on enhancing prevention of severe psychopathology and suicide risk during emerging adulthood and in high-risk populations.

In addition to her statistical genetics research, Dr. Docherty is Chair of the Suicide Working Group of the Psychiatric Genomics Consortium (PGC), she serves on the PGC Steering Committee, and she is a contributing PI/analyst to several other working groups (MDD, Anxiety, Schizophrenia, PTSD, ADHD, SUD, LAGC, and Gen-ECT-ic). Dr. Docherty is also active in bioethics initiatives relating to pharmacogenomics and psychiatric genetic testing, and serves as Chair of the International Society for Psychiatric Genetics (ISPG) Ethics, Position, & Policy Advisory Committee. Dr. Docherty also serves on the Biomarker and Treatment-Resistant Depression working groups of the National Network of Depression Centers (NNDC). Locally, Dr. Docherty leads analyses of ketamine intervention outcomes at HMHI, and she is teaching faculty and Associate Course Director of HMHI’s annual NIH-funded R25 workshop, Advanced Statistical Training for Imaging and Genetics.

Academic Locations

Research Statement

Docherty’s current NIMH-funded research aims involve 1) genetic subtyping of psychopathology to inform psychiatric nosology and treatment and 2) GWAS-based dimensional prediction of numerous mental and physical health outcomes (the phenome) across critical stages of human development. She is interested in the overall empirical refinement of psychiatric classification, and in enhanced prediction of severe psychopathology via genetic modeling.

Board Certification and Academic Information

Academic Departments Psychiatry - Assistant Professor
Academic Divisions Adult Psychiatry

Research Interests

  • Biological Psychiatry
  • Psychiatric Genetics
  • Genomic Analysis
  • Psychopathology
  • Depression
  • Schizophrenia and Disorders with Psychotic Features
  • Anxiety Disorders
  • Autism Spectrum Disorders
  • Genetic Risk for Psychopathology

Education History

Postdoctoral Fellowship Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University
Quantitative Genetics
Postdoctoral Fellow, 2016
Internship Minneapolis VA Health Care System
Clinical Psychology
Intern, 2013
Doctoral Training University of Missouri-Columbia
Clinical Psychology
Ph.D., 2013
Certification Yale School of Medicine
Early Assessment of Psychosis and High Risk
Certification, 2012
Post Graduate Training University of Colorado-Boulder
Advanced Structural Equation Modeling for Genetics Studies, Psychiatry
Certificate, 2012
Fellowship University of Minnesota, NIMH
Psychiatric Genetics
Predoctoral Fellow, 2012
Graduate Training University of Missouri-Columbia
Clinical Psychology
M.A., 2009
Undergraduate Oberlin College & Conservatory
English
B.A., 2002

Selected Publications - Journal Articles

Journal Article

  1. Kimbrel NA, Ashley-Koch AE, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, Hair LP, Huffman JE, Jacobson DA, Madduri RK, Trafton JA, Coon H, Docherty AR, Mullins N, Ruderfer DM, Harvey PD, McMahon BH, Oslin DW, Beckham JC, Hauser ER, Hauser MA, Million Veteran Program Suicide Exemplar Workgroup the International Suicide Genetics Consortium the Veterans Affairs Mid-Atlantic Mental Illness Research Education and Clinical Center Workgroup and the Veterans Affairs Million Veteran Program (2022). Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans. JAMA Psychiatry.
  2. Saunders GRB, Wang X, Chen F, Jang SK, Liu M, Wang C, Gao S, Jiang Y, Khunsriraksakul C, Otto JM, Addison C, Akiyama M, Albert CM, Aliev F, Alonso A, Arnett DK, Ashley-Koch AE, Ashrani AA, Barnes KC, Barr RG, Bartz TM, Becker DM, Bielak LF, Benjamin EJ, Bis JC, Bjornsdottir G, Blangero J, Bleecker ER, Boardman JD, Boerwinkle E, Boomsma DI, Boorgula MP, Bowden DW, Brody JA, Cade BE, Chasman DI, Chavan S, Chen YI, Chen Z, Cheng I, Cho MH, Choquet H, Cole JW, Cornelis MC, Cucca F, Curran JE, de Andrade M, Dick DM, Docherty AR, Duggirala R, Eaton CB, Ehringer MA, Esko T, Faul JD, Silva LF, Fiorillo E, Fornage M, Freedman BI, Gabrielsen ME, Garrett ME, Gharib SA, Gieger C, Gillespie N, Glahn DC, Gordon SD, Gu CC, Gu D, Gudbjartsson DF, Guo X, Haessler J, Hall ME, Haller T, Harris KM, He J, Herd P, Hewitt JK, Hickie I, Hidalgo B, Hokanson JE, Hopfer C, Hottenga J, Hou L, Huang H, Hung YJ, Hunter DJ, Hveem K, Hwang SJ, Hwu CM, Iacono W, Irvin MR, Jee YH, Johnson EO, Joo YY, Jorgenson E, Justice AE, Kamatani Y, Kaplan RC, Kaprio J, Kardia SLR, Keller MC, Kelly TN, Kooperberg C, Korhonen T, Kraft P, Krauter K, Kuusisto J, Laakso M, Lasky-Su J, Lee WJ, Lee JJ, Levy D, Li L, Li K, Li Y, Lin K, Lind PA, Liu C, Lloyd-Jones DM, Lutz SM, Ma J, Mgi R, Manichaikul A, Martin NG, Mathur R, Matoba N, McArdle PF, McGue M, McQueen MB, Medland SE, Metspalu A, Meyers DA, Millwood IY, Mitchell BD, Mohlke KL, Moll M, Montasser ME, Morrison AC, Mulas A, Nielsen JB, North KE, Oelsner EC, Okada Y, Orr V, Palmer ND, Palviainen T, Pandit A, Park SL, Peters U, Peters A, Peyser PA, Polderman TJC, Rafaels N, Redline S, Reed RM, Reiner AP, Rice JP, Rich SS, Richmond NE, Roan C, Rotter JI, Rueschman MN, Runarsdottir V, Saccone NL, Schwartz DA, Shadyab AH, Shi J, Shringarpure SS, Sicinski K, Skogholt AH, Smith JA, Smith NL, Sotoodehnia N, Stallings MC, Stefansson H, Stefansson K, Stitzel JA, Sun X, Syed M, Tal-Singer R, Taylor AE, Taylor KD, Telen MJ, Thai KK, Tiwari H, Turman C, Tyrfingsson T, Wall TL, Walters RG, Weir DR, Weiss ST, White WB, Whitfield JB, Wiggins KL, Willemsen G, Willer CJ, Winsvold BS, Xu H, Yanek LR, Yin J, Young KL, Young KA, Yu B, Zhao W, Zhou W, Zllner S, Zuccolo L, 23andMe Research Team, Biobank Japan Project, Batini C, Bergen AW, Bierut LJ, David SP, Gagliano Taliun SA, Hancock DB, Jiang B, Munaf MR, Thorgeirsson TE, Liu DJ, Vrieze S (2022). Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature, 612(7941), 720-724.
  3. Koraishy FM, Mann FD, Waszczuk MA, Kuan PF, Jonas K, Yang X, Docherty A, Shabalin A, Clouston S, Kotov R, Luft B (2022). Polygenic association of glomerular filtration rate decline in world trade center responders. BMC Nephrol, 23(1), 347.
  4. Li QS, Shabalin AA, DiBlasi E, Gopal S, Canuso CM, FinnGen International Suicide Genetics Consortium, Palotie A, Drevets WC, Docherty AR, Coon H (2022). Genome-wide association study meta-analysis of suicide death and suicidal behavior. Mol Psychiatry.
  5. Mirza S, Docherty AR, Bakian A, Coon H, Soares JC, Walss-Bass C, Fries GR (2022). Genetics and epigenetics of self-injurious thoughts and behaviors: Systematic review of the suicide literature and methodological considerations. Am J Med Genet B Neuropsychiatr Genet, 189, 221-246.
  6. Lencz T, Sabatello M, Docherty A, Peterson RE, Soda T, Austin J, Bierut L, Crepaz-Keay D, Curtis D, Degenhardt F, Huckins L, Lazaro-Munoz G, Mattheisen M, Meiser B, Peay H, Rietschel M, Walss-Bass C, Davis LK (2022). Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits. Lancet Psychiatry, 9, 838-844.
  7. Love T, Shabalin AA, Kember RL, Docherty AR, Zhou H, Koppelmans V, Gelernter J, Baker AK, Hartwell E, Dubroff J, Zubieta JK, Kranzler HR (2022). Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function. Neuropsychopharmacology, 47(10), 1784-1790.
  8. Kimbrel NA, Ashley-Koch AE, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, Hair LP, Huffman JE, Jacobson DA, Madduri RK, Trafton JA, Coon H, Docherty AR, Kang J, Mullins N, Ruderfer DM, VA Million Veteran Program MVP, MVP Suicide Exemplar Workgroup, International Suicide Genetics Consortium, Harvey PD, McMahon BH, Oslin DW, Hauser ER, Hauser MA, Beckham JC (2022). A genome-wide association study of suicide attempts in the million veterans program identifies evidence of pan-ancestry and ancestry-specific risk loci. Mol Psychiatry, 27, 2264-2272.
  9. Coon H, Shabalin A, Bakian AV, DiBlasi E, Monson ET, Kirby A, Chen D, Fraser A, Yu Z, Staley M, Callor WB, Christensen ED, Crowell SE, Gray D, Crockett DK, Li QS, Keeshin B, Docherty AR (2022). Extended familial risk of suicide death is associated with younger age at death and elevated polygenic risk of suicide. Am J Med Genet B Neuropsychiatr Genet, 189, 60-73.
  10. Kotov R, Jonas KG, Lian W, Docherty AR, Carpenter WT (2022). Reconceptualizing schizophrenia in the Hierarchical Taxonomy Of Psychopathology (HiTOP). Schizophr Res, 242, 73-77.
  11. Mullins N, Kang J, Campos AI, Coleman JRI, Edwards AC, Galfalvy H, Levey DF, Lori A, Shabalin A, Starnawska A, Su MH, Watson HJ, Adams M, Awasthi S, Gandal M, Hafferty JD, Hishimoto A, Kim M, Okazaki S, Otsuka I, Ripke S, Ware EB, Bergen AW, Berrettini WH, Bohus M, Brandt H, Chang X, Chen WJ, Chen HC, Crawford S, Crow S, DiBlasi E, Duriez P, Fernndez-Aranda F, Fichter MM, Gallinger S, Glatt SJ, Gorwood P, Guo Y, Hakonarson H, Halmi KA, Hwu HG, Jain S, Jamain S, Jimnez-Murcia S, Johnson C, Kaplan AS, Kaye WH, Keel PK, Kennedy JL, Klump KL, Li D, Liao SC, Lieb K, Lilenfeld L, Liu CM, Magistretti PJ, Marshall CR, Mitchell JE, Monson ET, Myers RM, Pinto D, Powers A, Ramoz N, Roepke S, Rozanov V, Scherer SW, Schmahl C, Sokolowski M, Strober M, Thornton LM, Treasure J, Tsuang MT, Witt SH, Woodside DB, Yilmaz Z, Zillich L, Adolfsson R, Agartz I, Air TM, Alda M, Alfredsson L, Andreassen OA, Anjorin A, Appadurai V, Soler Artigas M, Van der Auwera S, Azevedo MH, Bass N, Bau CHD, Baune BT, Bellivier F, Berger K, Biernacka JM, Bigdeli TB, Binder EB, Boehnke M, Boks MP, Bosch R, Braff DL, Bryant R, Budde M, Byrne EM, Cahn W, Casas M, Castelao E, Cervilla JA, Chaumette B, Cichon S, Corvin A, Craddock N, Craig D, Degenhardt F, Djurovic S, Edenberg HJ, Fanous AH, Foo JC, Forstner AJ, Frye M, Fullerton JM, Gatt JM, Gejman PV, Giegling I, Grabe HJ, Green MJ, Grevet EH, Grigoroiu-Serbanescu M, Gutierrez B, Guzman-Parra J, Hamilton SP, Hamshere ML, Hartmann A, Hauser J, Heilmann-Heimbach S, Hoffmann P, Ising M, Jones I, Jones LA, Jonsson L, Kahn RS, Kelsoe JR, Kendler KS, Kloiber S, Koenen KC, Kogevinas M, Konte B, Krebs MO, Landn M, Lawrence J, Leboyer M, Lee PH, Levinson DF, Liao C, Lissowska J, Lucae S, Mayoral F, McElroy SL, McGrath P, McGuffin P, McQuillin A, Medland SE, Mehta D, Melle I, Milaneschi Y, Mitchell PB, Molina E, Morken G, Mortensen PB, Mller-Myhsok B, Nievergelt C, Nimgaonkar V, Nthen MM, ODonovan MC, Ophoff RA, Owen MJ, Pato C, Pato MT, Penninx BWJH, Pimm J, Pistis G, Potash JB, Power RA, Preisig M, Quested D, Ramos-Quiroga JA, Reif A, Ribass M, Richarte V, Rietschel M, Rivera M, Roberts A, Roberts G, Rouleau GA, Rovaris DL, Rujescu D, Snchez-Mora C, Sanders AR, Schofield PR, Schulze TG, Scott LJ, Serretti A, Shi J, Shyn SI, Sirignano L, Sklar P, Smeland OB, Smoller JW, Sonuga-Barke EJS, Spalletta G, Strauss JS, witkowska B, Trzaskowski M, Turecki G, Vilar-Rib L, Vincent JB, Vlzke H, Walters JTR, Shannon Weickert C, Weickert TW, Weissman MM, Williams LM, Wray NR, Zai CC, Ashley-Koch AE, Beckham JC, Hauser ER, Hauser MA, Kimbrel NA, Lindquist JH, McMahon B, Oslin DW, Qin X, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Eating Disorders Working Group of the Psychiatric Genomics Consortium, German Borderline Genomics Consortium, MVP Suicide Exemplar Workgroup, VA Million Veteran Program, Agerbo E, Brglum AD, Breen G, Erlangsen A, Esko T, Gelernter J, Hougaard DM, Kessler RC, Kranzler HR, Li QS, Martin NG, McIntosh AM, Mors O, Nordentoft M, Olsen CM, Porteous D, Ursano RJ, Wasserman D, Werge T, Whiteman DC, Bulik CM, Coon H, Demontis D, Docherty AR, Kuo PH, Lewis CM, Mann JJ, Rentera ME, Smith DJ, Stahl EA, Stein MB, Streit F, Willour V, Ruderfer DM (2021). Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors. Biol Psychiatry, 91(3), 313-327.
  12. Watson D, Levin-Aspenson HF, Waszczuk MA, Conway CC, Dalgleish T, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Hobbs KA, Michelini G, Nelson BD, Sellbom M, Slade T, South SC, Sunderland M, Waldman I, Witthft M, Wright AGC, Kotov R, Krueger RF, HiTOP Utility Workgroup (2022). Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum. World Psychiatry, 21(1), 26-54.
  13. Blokland GAM, Grove J, Chen CY, Cotsapas C, Tobet S, Handa R, Schizophrenia Working Group of the Psychiatric Genomics Consortium, St Clair D, Lencz T, Mowry BJ, Periyasamy S, Cairns MJ, Tooney PA, Wu JQ, Kelly B, Kirov G, Sullivan PF, Corvin A, Riley BP, Esko T, Milani L, Jnsson EG, Palotie A, Ehrenreich H, Begemann M, Steixner-Kumar A, Sham PC, Iwata N, Weinberger DR, Gejman PV, Sanders AR, Buxbaum JD, Rujescu D, Giegling I, Konte B, Hartmann AM, Bramon E, Murray RM, Pato MT, Lee J, Melle I, Molden E, Ophoff RA, McQuillin A, Bass NJ, Adolfsson R, Malhotra AK, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Martin NG, Fullerton JM, Mitchell PB, Schofield PR, Forstner AJ, Degenhardt F, Schaupp S, Comes AL, Kogevinas M, Guzman-Parra J, Reif A, Streit F, Sirignano L, Cichon S, Grigoroiu-Serbanescu M, Hauser J, Lissowska J, Mayoral F, Mller-Myhsok B, witkowska B, Schulze TG, Nthen MM, Rietschel M, Kelsoe J, Leboyer M, Jamain S, Etain B, Bellivier F, Vincent JB, Alda M, ODonovan C, Cervantes P, Biernacka JM, Frye M, McElroy SL, Scott LJ, Stahl EA, Landn M, Hamshere ML, Smeland OB, Djurovic S, Vaaler AE, Andreassen OA, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Baune BT, Air T, Preisig M, Uher R, Levinson DF, Weissman MM, Potash JB, Shi J, Knowles JA, Perlis RH, Lucae S, Boomsma DI, Penninx BWJH, Hottenga JJ, de Geus EJC, Willemsen G, Milaneschi Y, Tiemeier H, Grabe HJ, Teumer A, Van der Auwera S, Vlker U, Hamilton SP, Magnusson PKE, Viktorin A, Mehta D, Mullins N, Adams MJ, Breen G, McIntosh AM, Lewis CM, Sex Differences Cross-Disorder Analysis Group of the Psychiatric Genomics Consortium, iPSYCH, Hougaard DM, Nordentoft M, Mors O, Mortensen PB, Werge T, Als TD, Brglum AD, Petryshen TL, Smoller JW, Goldstein JM (2021). Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders. Biol Psychiatry, 91(1), 102-117.
  14. Cicero DC, Jonas KG, Chmielewski M, Martin EA, Docherty AR, Berzon J, Haltigan JD, Reininghaus U, Caspi A, Graziolplene RG, Kotov R (2021). Development of the Thought Disorder Measure for the Hierarchical Taxonomy of Psychopathology. Assessment, 29(1), 46-61.
  15. DiBlasi E, Shabalin AA, Monson ET, Keeshin BR, Bakian AV, Kirby AV, Ferris E, Chen D, William N, Gaj E, Klein M, Jerominski L, Callor WB, Christensen E, Smith KR, Fraser A, Yu Z, Gray D, PsychChip Investigators of the Psychiatric Genomics Consortium, Camp NJ, Stahl EA, Li QS, Docherty AR, Coon H (2021). Rare protein-coding variants implicate genes involved in risk of suicide death. Am J Med Genet B Neuropsychiatr Genet, 186(8), 508-520.
  16. Docherty A, Kious B, Brown T, Francis L, Stark L, Keeshin B, Botkin J, DiBlasi E, Gray D, Coon H (2021). Ethical concerns relating to genetic risk scores for suicide. Am J Med Genet B Neuropsychiatr Genet, 186(8), 433-444.
  17. Colbert SMC, Hatoum AS, Shabalin A, Li QS, Coon H, Nelson EC, Agrawal A, Docherty AR, Johnson EC (2021). Exploring the genetic overlap of suicide-related behaviors and substance use disorders. Am J Med Genet B Neuropsychiatr Genet, 186(8), 445-455.
  18. Alkelai A, Greenbaum L, Docherty AR, Shabalin AA, Povysil G, Malakar A, Hughes D, Delaney SL, Peabody EP, McNamara J, Gelfman S, Baugh EH, Zoghbi AW, Harms MB, Hwang HS, Grossman-Jonish A, Aggarwal V, Heinzen EL, Jobanputra V, Pulver AE, Lerer B, Goldstein DB (2021). The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders. Mol Psychiatry, 27, 1435-1447.
  19. DiBlasi E, Kang J, Docherty AR (2021). Genetic contributions to suicidal thoughts and behaviors. Psychol Med, 51(13), 2148-2155.
  20. Docherty AR, Bakian AV, DiBlasi E, Shabalin AA, Chen D, Keeshin B, Monson E, Christensen ED, Li Q, Gray D, Coon H (2021). Suicide and psychosis: Results from a population-based cohort of suicide death (N = 4380). Schizophr Bull, 48, 457-462.
  21. Waszczuk MA, Miao J, Docherty AR, Shabalin A, Jonas KG, Michelini G, Kotov R (2021). General vs. specific vulnerabilities: Polygenic risk scores and higher-order psychopathology dimensions in the Adolescent Brain Cognitive Development (ABCD) study. Psychol Med, 1-10.
  22. Bakian AV, Chen D, Zhang C, Hanson H, Docherty AR, Keeshin B, Gray D, Smith K, VanDerslice J, Yu D, Zhang Y Coon H (2021). A population-wide analysis of the familial risk of suicide in Utah, USA. Psychol Med, 1-10.
  23. Johnson EC, Aliev F, Meyers JL, Salvatore JE, Tillman R, Chang Y, Docherty AR, Bogdan R, Acion L, Chan G, Chorlian DB, Kamarajan C, Kuperman S, Pandey A, Plawecki MH, Schuckit M, Tischfield J, Edenberg HJ, Bucholz KK, Nurnberger JI, Porjesz B, Hesselbrock V, Dick DM, Kramer JR, Agrawal A (2021). Associations between Suicidal Thoughts and Behaviors and Genetic Liability for Cognitive Performance, Depression, and Risk-Taking in a High-Risk Sample. Complex Psychiatry, 7(1-2), 34-44.
  24. Monson ET, Shabalin AA, Docherty AR, DiBlasi E, Bakian AV, Li QS, Gray D, Keeshin B, Crowell SE, Mullins N, Willour VL, Coon H (2021). Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach. Transl Psychiatry, 11(1), 379.
  25. Johnson E, Aliev F, Meyers J, Salvatore JE, Tilman R, Chang Y, Docherty AR, Bogdan R, Acion L, CHan G, Chorlian DB, Kamarajan C, Kuperman S, Pandey A, Plawecki MH, Schuckit M, Tischfield J, Edenberg HJ, Bucholz KK, Nurnberger JI, Porjesz B, Hesselbrock V, Dick DM, Kramer JR, Agrawal A (2021). Associations between suicidal thoughts and behaviors and genetic liability for cognitive performance, depression, and risk-taking in a high-risk sample. Complex Psychiatry, 7(1-2), 34-44.
  26. Cohen AS, Cox CR, Cowan TM, Masucci MD, Le TP, Docherty AR, Bedwell JS (2021). High predictive accuracy of negative schizotypy with acoustic measures. Clin Psychol Sci, 10(2), 310-323.
  27. Kim H, Turiano NA, Forbes MK, Kotov R, Krueger RF, Eaton NR, HiTOP Utility Workgroup (2021). Internalizing psychopathology and all-cause mortality: a comparison of transdiagnostic vs. diagnosis-based risk prediction. World Psychiatry, 20(2), 276-282.
  28. McGuire D, Jiang Y, Liu M, Weissenkampen JD, Eckert S, Yang L, Chen F, GWAS and Sequencing Consortium of Alcohol and Nicotine Use GSCAN, Berg A, Vrieze S, Jiang B, Li Q, Liu DJ (2021). Model-based assessment of replicability for genome-wide association meta-analysis. Nat Commun, 12(1), 1964.
  29. Kious BM, Docherty AR, Botkin JR, Brown TR, Francis LP, Gray DD, Keeshin BR, Stark LA, Witte B, Coon H (2020). Ethical and public health implications of genetic testing for suicide risk: family and survivor perspectives. Genet Med, 23(2), 289-297.
  30. Kious BM, Docherty AR, Botkin JR, Brown TR, Francis LP, Gray DD, Keeshin BR, Stark LA, Witte B, Coon H (2020). Correction: Ethical and public health implications of genetic testing for suicide risk: family and survivor perspectives. Genet Med, 23(2), 425.
  31. Fonseca-Pedrero E, Debban M, Rodrguez-Testal JF, Cohen AS, Docherty AR, Ortuo-Sierra J (2021). Schizotypy: The way ahead. Psicothema, 33(1), 16-27.
  32. Munn-Chernoff MA, Johnson EC, Chou YL, Coleman JRI, Thornton LM, Walters RK, Yilmaz Z, Baker JH, Hbel C, Gordon S, Medland SE, Watson HJ, Gaspar HA, Bryois J, Hinney A, Lepp VM, Mattheisen M, Ripke S, Yao S, Giusti-Rodrguez P, Hanscombe KB, Adan RAH, Alfredsson L, Ando T, Andreassen OA, Berrettini WH, Boehm I, Boni C, Boraska Perica V, Buehren K, Burghardt R, Cassina M, Cichon S, Clementi M, Cone RD, Courtet P, Crow S, Crowley JJ, Danner UN, Davis OSP, de Zwaan M, Dedoussis G, Degortes D, DeSocio JE, Dick DM, Dikeos D, Dina C, Dmitrzak-Weglarz M, Docampo E, Duncan LE, Egberts K, Ehrlich S, Escarams G, Esko T, Estivill X, Farmer A, Favaro A, Fernndez-Aranda F, Fichter MM, Fischer K, Fcker M, Foretova L, Forstner AJ, Forzan M, Franklin CS, Gallinger S, Giegling I, Giuranna J, Gonidakis F, Gorwood P, Gratacos Mayora M, Guillaume S, Guo Y, Hakonarson H, Hatzikotoulas K, Hauser J, Hebebrand J, Helder SG, Herms S, Herpertz-Dahlmann B, Herzog W, Huckins LM, Hudson JI, Imgart H, Inoko H, Janout V, Jimnez-Murcia S, Juli A, Kalsi G, Kaminsk D, Karhunen L, Karwautz A, Kas MJH, Kennedy JL, Keski-Rahkonen A, Kiezebrink K, Kim YR, Klump KL, Knudsen GPS, La Via MC, Le Hellard S, Levitan RD, Li D, Lilenfeld L, Lin BD, Lissowska J, Luykx J, Magistretti PJ, Maj M, Mannik K, Marsal S, Marshall CR, Mattingsdal M, McDevitt S, McGuffin P, Metspalu A, Meulenbelt I, Micali N, Mitchell K, Monteleone AM, Monteleone P, Nacmias B, Navratilova M, Ntalla I, OToole JK, Ophoff RA, Padyukov L, Palotie A, Pantel J, Papezova H, Pinto D, Rabionet R, Raevuori A, Ramoz N, Reichborn-Kjennerud T, Ricca V, Ripatti S, Ritschel F, Roberts M, Rotondo A, Rujescu D, Rybakowski F, Santonastaso P, Scherag A, Scherer SW, Schmidt U, Schork NJ, Schosser A, Seitz J, Slachtova L, Slagboom PE, Slof-Opt Landt MCT, Slopien A, Sorbi S, witkowska B, Szatkiewicz JP, Tachmazidou I, Tenconi E, Tortorella A, Tozzi F, Treasure J, Tsitsika A, Tyszkiewicz-Nwafor M, Tziouvas K, van Elburg AA, van Furth EF, Wagner G, Walton E, Widen E, Zeggini E, Zerwas S, Zipfel S, Bergen AW, Boden JM, Brandt H, Crawford S, Halmi KA, Horwood LJ, Johnson C, Kaplan AS, Kaye WH, Mitchell J, Olsen CM, Pearson JF, Pedersen NL, Strober M, Werge T, Whiteman DC, Woodside DB, Grove J, Henders AK, Larsen JT, Parker R, Petersen LV, Jordan J, Kennedy MA, Birgegrd A, Lichtenstein P, Norring C, Landn M, Mortensen PB, Polimanti R, McClintick JN, Adkins AE, Aliev F, Bacanu SA, Batzler A, Bertelsen S, Biernacka JM, Bigdeli TB, Chen LS, Clarke TK, Degenhardt F, Docherty AR, Edwards AC, Foo JC, Fox L, Frank J, Hack LM, Hartmann AM, Hartz SM, Heilmann-Heimbach S, Hodgkinson C, Hoffmann P, Hottenga JJ, Konte B, Lahti J, Lahti-Pulkkinen M, Lai D, Ligthart L, Loukola A, Maher BS, Mbarek H, McIntosh AM, McQueen MB, Meyers JL, Milaneschi Y, Palviainen T, Peterson RE, Ryu E, Saccone NL, Salvatore JE, Sanchez-Roige S, Schwandt M, Sherva R, Streit F, Strohmaier J, Thomas N, Wang JC, Webb BT, Wedow R, Wetherill L, Wills AG, Zhou H, Boardman JD, Chen D, Choi DS, Copeland WE, Culverhouse RC, Dahmen N, Degenhardt L, Domingue BW, Frye MA, Gebel W, Hayward C, Ising M, Keyes M, Kiefer F, Koller G, Kramer J, Kuperman S, Lucae S, Lynskey MT, Maier W, Mann K, Mnnist S, Mller-Myhsok B, Murray AD, Nurnberger JI, Preuss U, Rikknen K, Reynolds MD, Ridinger M, Scherbaum N, Schuckit MA, Soyka M, Treutlein J, Witt SH, Wodarz N, Zill P, Adkins DE, Boomsma DI, Bierut LJ, Brown SA, Bucholz KK, Costello EJ, de Wit H, Diazgranados N, Eriksson JG, Farrer LA, Foroud TM, Gillespie NA, Goate AM, Goldman D, Grucza RA, Hancock DB, Harris KM, Hesselbrock V, Hewitt JK, Hopfer CJ, Iacono WG, Johnson EO, Karpyak VM, Kendler KS, Kranzler HR, Krauter K, Lind PA, McGue M, MacKillop J, Madden PAF, Maes HH, Magnusson PKE, Nelson EC, Nthen MM, Palmer AA, Penninx BWJH, Porjesz B, Rice JP, Rietschel M, Riley BP, Rose RJ, Shen PH, Silberg J, Stallings MC, Tarter RE, Vanyukov MM, Vrieze S, Wall TL, Whitfield JB, Zhao H, Neale BM, Wade (2020). Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. Addict Biol, 26(1), e12880.
  33. Krueger RF, Kotov R, Watson D, Forbes MK, Eaton NR, Ruggero CJ, Simms LJ, Widiger TA, Achenbach TM, Bach B, Bagby RM, Bornovalova MA, Carpenter WT, Chmielewski M, Cicero DC, Clark LA, Conway C, DeClercq B, DeYoung CG, Docherty AR, Drislane LE, First MB, Forbush KT, Hallquist M, Haltigan JD, Hopwood CJ, Ivanova MY, Jonas KG, Latzman RD, Markon KE, Miller JD, Morey LC, Mullins-Sweatt SN, Ormel J, Patalay P, Patrick CJ, Pincus AL, Regier DA, Reininghaus U, Rescorla LA, Samuel DB, Sellbom M, Shackman AJ, Skodol A, Slade T, South SC, Sunderland M, Tackett JL, Venables NC, Waldman ID, Waszczuk MA, Waugh MH, Wright AGC, Zald DH, Zimmermann J (2021). Les progrès dans la réalisation de la classification quantitative de la psychopathologie. Ann Med Psychol (Paris), 179(1), 95-106.
  34. Chatzinakos C, Georgiadis F, Lee D, Cai N, Vladimirov VI, Docherty A, Webb BT, Riley BP, Flint J, Kendler KS, Daskalakis NP, Bacanu SA (2020). TWAS pathway method greatly enhances the number of leads for uncovering the molecular underpinnings of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet, 183(8), 454-463.
  35. Krueger RF, Hobbs KA, Conway CC, Dick DM, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Keyes KM, Latzman RD, Michelini G, Patrick CJ, Sellbom M, Slade T, South S, Sunderland M, Tackett J, Waldman I, Waszczuk MA, Wright AG, Zald DH, Watson D, Kotov R the HiTOP Utility Working Group (2020). Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum. . World Psychiatry, 20, 171-193.
  36. Kotov R, Jonas KG, Carpenter WT, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Hobbs K, Reininghaus U, Slade T, South SC, Sunderland M, Waszczuk MA, Widiger TA, Wright AGC, Zald DH, Krueger RF, Watson D HiTOP Utility Workgroup (2020). Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum. World Psychiatry, 19(2), 151-172.
  37. Coon H, Darlington TM, DiBlasi E, Callor WB, Ferris E, Fraser A, Yu Z, William N, Das SC, Crowell SE, Chen D, Anderson JS, Klein M, Jerominski L, Cannon D, Shabalin A, Docherty A, Williams M, Smith KR, Keeshin B, Bakian AV, Christensen E, Li QS, Camp NJ, Gray D (2018). Genome-wide significant regions in 43 Utah high-risk families implicate multiple genes involved in risk for completed suicide. Mol Psychiatry, 25(11), 3077-3090.
  38. Waszczuk MA, Docherty AR, Shabalin AA, Miao J, Yang X, Kuan PF, Bromet E, Kotov R, Luft BJ (2020). Polygenic prediction of PTSD trajectories in 9/11 responders. Psychol Med, 1-9.
  39. Johnson EC, Demontis D, Thorgeirsson TE, Walters RK, Polimanti R, Hatoum AS, Sanchez-Roige S, Paul SE, Wendt FR, Clarke TK, Lai D, Reginsson GW, Zhou H, He J, Baranger DAA, Gudbjartsson DF, Wedow R, Adkins DE, Adkins AE, Alexander J, Bacanu SA, Bigdeli TB, Boden J, Brown SA, Bucholz KK, Bybjerg-Grauholm J, Corley RP, Degenhardt L, Dick DM, Domingue BW, Fox L, Goate AM, Gordon SD, Hack LM, Hancock DB, Hartz SM, Hickie IB, Hougaard DM, Krauter K, Lind PA, McClintick JN, McQueen MB, Meyers JL, Montgomery GW, Mors O, Mortensen PB, Nordentoft M, Pearson JF, Peterson RE, Reynolds MD, Rice JP, Runarsdottir V, Saccone NL, Sherva R, Silberg JL, Tarter RE, Tyrfingsson T, Wall TL, Webb BT, Werge T, Wetherill L, Wright MJ, Zellers S, Adams MJ, Bierut LJ, Boardman JD, Copeland WE, Farrer LA, Foroud TM, Gillespie NA, Grucza RA, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono WG, Johnson EO, Kendler KS, Kennedy MA, Kranzler HR, Madden PAF, Maes HH, Maher BS, Martin NG, McGue M, McIntosh AM, Medland SE, Nelson EC, Porjesz B, Riley BP, Stallings MC, Vanyukov MM, Vrieze S Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Davis LK, Bogdan R, Gelernter J, Edenberg HJ, Stefansson K, Brglum AD, Agrawal A (2020). A large-scale genome-wide association study meta-analysis of cannabis use disorder. Lancet Psychiatry.
  40. Docherty AR, Shabalin AA, DiBlasi E, Monson E, Mullins N, Adkins DE, Bacanu SA, Bakian AV, Crowell S, Darlington T, Callor W, Christensen E, Gray D, Keeshin B, Klein M, Anderson JS, Jerominski L, Hayward C, Porteous D, McIntosh A, Li Q, Coon H (2020). Genome-wide association analysis of suicide death and polygenic prediction of clinical antecedents. Am J Psychiatry, 177(10), 917-927.
  41. DiBlasi E, Kirby AV, Gaj E, Docherty AR, Keeshin BR, Bakian AV, Coon H (2020). Genetic links between autism and suicidal behavior: A preliminary investigation. J Autism Dev Disord, 50(10), 3525-3530.
  42. Soda T, McLoughlin DM, Clark SR, Oltedal L, Kessler U, Haavik J, Bousman C, Smith DJ, Bioque M, Clements CC, Loo C, Vila-Rodriguez F, Minelli A, Mickey BJ, Milev R, Docherty AR, Langan Martin J, Achtyes ED, Arolt V, Redlich R, Dannlowski U, Cardoner N, Clare E, Craddock N, Di Florio A, Dmitrzak-Weglarz M, Forty L, Gordon-Smith K, Husain M, Ingram WM, Jones L, Jones I, Juruena M, Kirov G, Landn M, Mller DJ, Nordenskld A, Plsson E, Paul M, Permoda A, Pliszka B, Rea J, Schubert KO, Sonnen JA, Soria V, Stageman W, Takamiya A, Urretavizacaya M, Watson S, Zavorotny M, Young AH, Vieta E, Rybakowski JK, Gennarelli M, Zandi PP, Sullivan PF, Baune BT (2019). International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic). Eur Arch Psychiatry Clin Neurosci, 270(7), 921-932.
  43. Docherty AR, Moscati A, Bigdeli TB, Edwards AC, Peterson RE, Adkins DE, Anderson JS, Flint J, Kendler KS, Bacanu SA (2019). Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE. Psychol Med, 50(5), 793-798.
  44. Docherty AR, Shabalin AA, Adkins DE, Mann F, Krueger RF, Bacanu SA, Campbell A, Hayward C, Porteous DJ, McIntosh AM, Kendler KS (2020). Molecular Genetic Risk for Psychosis Is Associated With Psychosis Risk Symptoms in a Population-Based UK Cohort: Findings From Generation Scotland. Schizophr Bull, 46(5), 1045-1052.
  45. Perkins ER, Joyner KJ, Patrick CJ, Bartholow BD, Latzman RD, DeYoung CG, Kotov R, Reininghaus U, Cooper SE, Afzali MH, Docherty AR, Dretsch MN, Eaton NR, Goghari VM, Haltigan JD, Krueger RF, Martin EA, Michelini G, Ruocco AC, Tackett JL, Venables NC, Waldman ID, Zald DH (2020). Neurobiology and the Hierarchical Taxonomy of Psychopathology: progress toward ontogenetically informed and clinically useful nosology
. Dialogues Clin Neurosci, 22(1), 51-63.
  46. Waszczuk MA, Eaton NR, Krueger RF, Shackman AJ, Waldman ID, Zald DH, Lahey BB, Patrick CJ, Conway CC, Ormel J, Hyman SE, Fried EI, Forbes MK, Docherty AR, Althoff RR, Bach B, Chmielewski M, DeYoung CG, Forbush KT, Hallquist M, Hopwood CJ, Ivanova MY, Jonas KG, Latzman RD, Markon KE, Mullins-Sweatt SN, Pincus AL, Reininghaus U, South SC, Tackett JL, Watson D, Wright AGC, Kotov R (2019). Redefining phenotypes to advance psychiatric genetics: Implications from hierarchical taxonomy of psychopathology. J Abnorm Psychol, 129(2), 143-161.
  47. Ruggero CJ, Kotov R, Hopwood CJ, First M, Clark LA, Skodol AE, Mullins-Sweatt SN, Patrick CJ, Bach B, Cicero DC, Docherty A, Simms LJ, Bagby RM, Krueger RF, Callahan JL, Chmielewski M, Conway CC, De Clercq B, Dornbach-Bender A, Eaton NR, Forbes MK, Forbush KT, Haltigan JD, Miller JD, Morey LC, Patalay P, Regier DA, Reininghaus U, Shackman AJ, Waszczuk MA, Watson D, Wright AGC, Zimmermann J (2019). Integrating the Hierarchical Taxonomy of Psychopathology (HiTOP) into clinical practice. J Consult Clin Psychol, 87(12), 1069-1084.
  48. Shade J, Coon H, Docherty AR (2019). Ethical implications of using biobanks and population databases for genetic suicide research. Am J Med Genet B Neuropsychiatr Genet, 180(8), 601-608.
  49. Lee P, Smoller JDocherty AR, Cross Disorder Working Group of the Psychiatric Genomics Consortium (2019). Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell, 179(7), 1469-1482.
  50. Soda, T, Sullivan, P, ECT Working Group of the Psychiatric Genomics Consortium, Baune, B (2019). A global initiative to investigate the genomics of severe depression and response to electroconvulsive therapy (ECT): The Genomics of ECT international consortium (GenECT-ic). Lancet Psychiatry.
  51. Li Z, Wang Y, Yan C, Cheung EFC, Docherty AR, Sham PC, Gur RE, Gur RC, Chan RCK (2019). Inheritance of Neural Substrates for Motivation and Pleasure. Psychol Sci, 30(8), 1205-1217.
  52. Greene AL, Eaton NR, Li K, Forbes MK, Krueger RF, Markon KE, Waldman ID, Cicero DC, Conway CC, Docherty AR, Fried EI, Ivanova MY, Jonas KG, Latzman RD, Patrick CJ, Reininghaus U, Tackett JL, Wright AGC, Kotov R (2019). Are fit indices used to test psychopathology structure biased? A simulation study. J Abnorm Psychol, 128, 740-764.
  53. Widiger TA, Bach B, Chmielewski M, Clark LA, DeYoung C, Hopwood CJ, Kotov R, Krueger RF, Miller JD, Morey LC, Mullins-Sweatt SN, Patrick CJ, Pincus AL, Samuel DB, Sellbom M, South SC, Tackett JL, Watson D, Waugh MH, Wright AGC, Zimmermann J, Bagby RM, Cicero DC, Conway CC, De Clercq B, Docherty AR, Eaton NR, Forbush KT, Haltigan JD, Ivanova MY, Latzman RD, Lynam DR, Markon KE, Reininghaus U, Thomas KM (2018). Criterion A of the AMPD in HiTOP. J Pers Assess, 101(4), 345-355.
  54. Anderson JS, Shade J, DiBlasi E, Shabalin AA, Docherty AR (2018). Polygenic risk scoring and prediction of mental health outcomes. Curr Opin Psychol, 27, 77-81.
  55. Lzaro-Muoz, G, Sabatello, M, Huckins, L, Peay, H, Degenhardt, F, Meiser, B, Lencz, T, Soda, T, Docherty, AR, Crepaz-Keay, D, Austin, J, Peterson, R, and Davis, L, on behalf of the ISPG Ethics Committee (2019). International Society of Psychiatric Genetics Ethics Committee: Issues Facing Us. Am J Med Genet B Neuropsychiatr Genet.
  56. Conway CC, Forbes MK, Forbush KT, Fried EI, Hallquist MN, Kotov R, Mullins-Sweatt SN, Shackman AJ, Skodol AE, South SC, Sunderland M, Waszczuk MA, Zald DH, Afzali MH, Bornovalova MA, Carragher N, Docherty AR, Jonas KG, Krueger RF, Patalay P, Pincus AL, Tackett JL, Reininghaus U, Waldman ID, Wright AGC, Zimmermann J, Bach B, Bagby RM, Chmielewski M, Cicero DC, Clark LA, Dalgleish T, DeYoung CG, Hopwood CJ, Ivanova MY, Latzman RD, Patrick CJ, Ruggero CJ, Samuel DB, Watson D, Eaton NR (2019). A Hierarchical Taxonomy of Psychopathology Can Transform Mental Health Research. Perspect Psychol Sci, 14(3), 419-436.
  57. Hopwood CJ, Bagby RM, Gralnick T, Ro E, Ruggero C, Mullins-Sweatt S, Kotov R, Bach B, Cicero DC, Krueger RF, Patrick CJ, Chmielewski M, DeYoung CG, Docherty AR, Eaton NR, Forbush KT, Ivanova MY, Latzman RD, Pincus AL, Samuel DB, Waugh MH, Wright AGC, Zimmermann J (2019). Integrating psychotherapy with the hierarchical taxonomy of psychopathology (HiTOP). J Psychother Integr.
  58. Chang LH, Couvy-Duchesne B, Liu M, Medland SE, Verhulst B, Benotsch EG, Hickie IB, Martin NG, Gillespie NA, GSCAN Consortium (2019). Association between polygenic risk for tobacco or alcohol consumption and liability to licit and illicit substance use in young Australian adults. Drug Alcohol Depend, 197, 271-279.
  59. Hopwood CJ, Krueger RF, Watson D, Widiger TA, Althoff RR, Ansell EB, Bach B, Bagby RM, Blais MA, Bornovalova MA, Chmielewski M, Cicero DC, Conway C, De Clerq B, De Fruyt F, Docherty AR, Eaton NR, Edens JF, Forbes MK, Forbush KT, Hengartner MP, Ivanova MY, Leising D, Lukowitsky MR, Lynam DR, Markon KE, Miller JD, Morey LC, Mullins-Sweatt SN, Ormel J, Patrick CJ, Pincus AL, Ruggero C, Samuel DB, Sellbom M, Tackett JL, Thomas KM, Trull TJ, Vachon DD, Waldman ID, Waszczuk MA, Waugh MH, Wright AGC, Yalch MM, Zald DH, Zimmermann J (2019). Commentary on "The Challenge of Transforming the Diagnostic System of Personality Disorders". J Pers Disord, 1-4.
  60. Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, Datta G, Davila-Velderrain J, McGuire D, Tian C, Zhan X, 23andMe Research Team, HUNT All-In Psychiatry, Choquet H, Docherty AR, Faul JD, Foerster JR, Fritsche LG, Gabrielsen ME, Gordon SD, Haessler J, Hottenga JJ, Huang H, Jang SK, Jansen PR, Ling Y, Mgi R, Matoba N, McMahon G, Mulas A, Orr V, Palviainen T, Pandit A, Reginsson GW, Skogholt AH, Smith JA, Taylor AE, Turman C, Willemsen G, Young H, Young KA, Zajac GJM, Zhao W, Zhou W, Bjornsdottir G, Boardman JD, Boehnke M, Boomsma DI, Chen C, Cucca F, Davies GE, Eaton CB, Ehringer MA, Esko T, Fiorillo E, Gillespie NA, Gudbjartsson DF, Haller T, Harris KM, Heath AC, Hewitt JK, Hickie IB, Hokanson JE, Hopfer CJ, Hunter DJ, Iacono WG, Johnson EO, Kamatani Y, Kardia SLR, Keller MC, Kellis M, Kooperberg C, Kraft P, Krauter KS, Laakso M, Lind PA, Loukola A, Lutz SM, Madden PAF, Martin NG, McGue M, McQueen MB, Medland SE, Metspalu A, Mohlke KL, Nielsen JB, Okada Y, Peters U, Polderman TJC, Posthuma D, Reiner AP, Rice JP, Rimm E, Rose RJ, Runarsdottir V, Stallings MC, Stankov A, Stefansson H, Thai KK, Tindle HA, Tyrfingsson T, Wall TL, Weir DR, Weisner C, Whitfield JB, Winsvold BS, Yin J, Zuccolo L, Bierut LJ, Hveem K, Lee JJ, Munaf MR, Saccone NL, Willer CJ, Cornelis MC, David SP, Hinds DA, Jorgenson E, Kaprio J, Stitzel JA, Stefansson K, Thorgeirsson TE, Abecasis G, Liu DJ, Vrieze S (2019). Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet, 51(2), 237-244.
  61. Eyler LT, Elman JA, Hatton SN, Gough S, Mischel AK, Hagler DJ, Franz CE, Docherty A, Fennema-Notestine C, Gillespie N, Gustavson D, Lyons MJ, Neale MC, Panizzon MS, Dale AM, Kremen WS (2019). Resting State Abnormalities of the Default Mode Network in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. J Alzheimers Dis, 70(1), 107-120.
  62. Walters RK, Polimanti R, Johnson EC, McClintick JN, Adams MJ, Adkins AE, Aliev F, Bacanu SA, Batzler A, Bertelsen S, Biernacka JM, Bigdeli TB, Chen LS, Clarke TK, Chou YL, Degenhardt F, Docherty AR, Edwards AC, Fontanillas P, Foo JC, Fox L, Frank J, Giegling I, Gordon S, Hack LM, Hartmann AM, Hartz SM, Heilmann-Heimbach S, Herms S, Hodgkinson C, Hoffmann P, Jan Hottenga J, Kennedy MA, Alanne-Kinnunen M, Konte B, Lahti J, Lahti-Pulkkinen M, Lai D, Ligthart L, Loukola A, Maher BS, Mbarek H, McIntosh AM, McQueen MB, Meyers JL, Milaneschi Y, Palviainen T, Pearson JF, Peterson RE, Ripatti S, Ryu E, Saccone NL, Salvatore JE, Sanchez-Roige S, Schwandt M, Sherva R, Streit F, Strohmaier J, Thomas N, Wang JC, Webb BT, Wedow R, Wetherill L, Wills AG, 23andMe Research Team, Boardman JD, Chen D, Choi DS, Copeland WE, Culverhouse RC, Dahmen N, Degenhardt L, Domingue BW, Elson SL, Frye MA, Gbel W, Hayward C, Ising M, Keyes M, Kiefer F, Kramer J, Kuperman S, Lucae S, Lynskey MT, Maier W, Mann K, Mnnist S, Mller-Myhsok B, Murray AD, Nurnberger JI, Palotie A, Preuss U, Rikknen K, Reynolds MD, Ridinger M, Scherbaum N, Schuckit MA, Soyka M, Treutlein J, Witt S, Wodarz N, Zill P, Adkins DE, Boden JM, Boomsma DI, Bierut LJ, Brown SA, Bucholz KK, Cichon S, Costello EJ, de Wit H, Diazgranados N, Dick DM, Eriksson JG, Farrer LA, Foroud TM, Gillespie NA, Goate AM, Goldman D, Grucza RA, Hancock DB, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono W, Johnson EO, Kaprio JA, Karpyak VM, Kendler KS, Kranzler HR, Krauter K, Lichtenstein P, Lind PA, McGue M, MacKillop J, Madden PAF, Maes HH, Magnusson P, Martin NG, Medland SE, Montgomery GW, Nelson EC, Nthen MM, Palmer AA, Pedersen NL, Penninx BWJH, Porjesz B, Rice JP, Rietschel M, Riley BP, Rose R, Rujescu D, Shen PH, Silberg J, Stallings MC, Tarter RE, Vanyukov MM, Vrieze S, Wall TL, Whitfield JB, Zhao H, Neale BM, Gelernter J, Edenberg HJ, Agrawal A (2018). Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat Neurosci, 21(12), 1656-1669.
  63. Docherty AR, Fonseca-Pedrero E, Debban M, Chan RCK, Linscott RJ, Jonas KG, Cicero DC, Green MJ, Simms LJ, Mason O, Watson D, Ettinger U, Waszczuk M, Rapp A, Grant P, Kotov R, DeYoung CG, Ruggero CJ, Eaton NR, Krueger RF, Patrick C, Hopwood C, ONeill FA, Zald DH, Conway CC, Adkins DE, Waldman ID, van Os J, Sullivan PF, Anderson JS, Shabalin AA, Sponheim SR, Taylor SF, Grazioplene RG, Bacanu SA, Bigdeli TB, Haenschel C, Malaspina D, Gooding DC, Nicodemus K, Schultze-Lutter F, Barrantes-Vidal N, Mohr C, Carpenter WT, Cohen AS (2018). Enhancing psychosis-spectrum nosology through an international data sharing initiative. Schizophr Bull, 44(suppl_2), S460-S467.
  64. Krueger RF, Kotov R, Watson D, Forbes MK, Eaton NR, Ruggero CJ, Simms LJ, Widiger TA, Achenbach TM, Bach B, Bagby RM, Bornovalova MA, Carpenter WT, Chmielewski M, Cicero DC, Clark LA, Conway C, DeClercq B, DeYoung CG, Docherty AR, Drislane LE, First MB, Forbush KT, Hallquist M, Haltigan JD, Hopwood CJ, Ivanova MY, Jonas KG, Latzman RD, Markon KE, Miller JD, Morey LC, Mullins-Sweatt SN, Ormel J, Patalay P, Patrick CJ, Pincus AL, Regier DA, Reininghaus U, Rescorla LA, Samuel DB, Sellbom M, Shackman AJ, Skodol A, Slade T, South SC, Sunderland M, Tackett JL, Venables NC, Waldman ID, Waszczuk MA, Waugh MH, Wright AGC, Zald DH, Zimmermann J (2018). Progress in achieving quantitative classification of psychopathology. World Psychiatry, 17(3), 282-293.
  65. Zhou HY, Wong KK, Shi LJ, Cui XL, Qian Y, Jiang WQ, Du YS, Lui SSY, Luo XR, Yi ZH, Cheung EFC, Docherty AR, Chan RCK (2018). Suspiciousness in young minds: Convergent evidence from non-clinical, clinical and community twin samples. Schizophr Res, 199, 135-141.
  66. Docherty AR, Moscati A, Dick D, Savage JE, Salvatore JE, Cooke M, Aliev F, Moore AA, Edwards AC, Riley BP, Adkins DE, Peterson R, Webb BT, Bacanu SA, Kendler KS (2018). Polygenic prediction of the phenome, across ancestry, in emerging adulthood. Psychol Med, 48(11), 1814-1823.
  67. Moore AA, Sawyers C, Adkins DE, Docherty AR (2018). Opportunities for an enhanced integration of neuroscience and genomics. Brain Imaging Behav, 12(4), 1211-1219.
  68. Edwards AC, Docherty AR, Moscati A, Bigdeli TB, Peterson RE, Webb BT, Bacanu SA, Hettema JM, Flint J, Kendler KS (2018). Polygenic risk for severe psychopathology among Europeans is associated with major depressive disorder in Han Chinese women. Psychol Med, 48(5), 777-789.
  69. Hopwood CJ, Kotov R, Krueger RF, Watson D, Widiger TA, Althoff RR, Ansell EB, Bach B, Michael Bagby R, Blais MA, Bornovalova MA, Chmielewski M, Cicero DC, Conway C, De Clercq B, De Fruyt F, Docherty AR, Eaton NR, Edens JF, Forbes MK, Forbush KT, Hengartner MP, Ivanova MY, Leising D, John Livesley W, Lukowitsky MR, Lynam DR, Markon KE, Miller JD, Morey LC, Mullins-Sweatt SN, Hans Ormel J, Patrick CJ, Pincus AL, Ruggero C, Samuel DB, Sellbom M, Slade T, Tackett JL, Thomas KM, Trull TJ, Vachon DD, Waldman ID, Waszczuk MA, Waugh MH, Wright AGC, Yalch MM, Zald DH, Zimmermann J (2017). The time has come for dimensional personality disorder diagnosis. Personal Ment Health, 12(1), 82-86.
  70. Docherty AR (2017). Leveraging psychiatric and medical genetics to understand comorbid depression and obesity. Br J Psychiatry, 211(2), 61-62.
  71. Docherty AR, Edwards AC, Yang F, Peterson RE, Sawyers C, Adkins DE, Moore AA, Webb BT, Bacanu SA, Flint J, Kendler KS (2017). Age of onset and family history as indicators of polygenic risk for major depression. Depress Anxiety, 34(5), 446-452.
  72. Merrill AM, Karcher NR, Cicero DC, Becker TM, Docherty AR, Kerns JG (2017). Evidence that communication impairment in schizophrenia is associated with generalized poor task performance. Psychiatry Res, 249, 172-179.
  73. Edwards AC, Aggen SH, Cai N, Bigdeli TB, Peterson RE, Docherty AR, Webb BT, Bacanu SA, Flint J, Kendler KS (2016). Chronicity of depression and molecular markers in a large sample of Han Chinese women. Depress Anxiety, 33(11), 1048-1054.
  74. Docherty AR, Moscati A, Peterson R, Edwards AC, Adkins DE, Bacanu SA, Bigdeli TB, Webb BT, Flint J, Kendler KS (2016). SNP-based heritability estimates of the personality dimensions and polygenic prediction of both neuroticism and major depression: findings from CONVERGE. Transl Psychiatry, 6(10), e926.
  75. Docherty AR, Moscati AA, Fanous AH (2016). Cross-disorder psychiatric genomics. Curr Behav Neurosci Rep, 3(3), 256-263.
  76. Docherty AR (2016). Genomic Approaches to Phenotype Prediction. JAMA Psychiatry, 73(5), 536.
  77. Edwards AC, Bigdeli TB, Docherty AR, Bacanu S, Lee D, de Candia TR, Moscati A, Thiselton DL, Maher BS, Wormley BK, Walsh D, ONeill FA, Kendler KS, Riley BP, Fanous AH (2016). Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. Schizophr Bull, 42(2), 279-87.
  78. Docherty AR, Kremen WS, Panizzon MS, Prom-Wormley EC, Franz CE, Lyons MJ, Eaves LJ, Neale MC (2015). Comparison of Twin and Extended Pedigree Designs for Obtaining Heritability Estimates. Behav Genet, 45(4), 461-6.
  79. Panizzon MS, Neale MC, Docherty AR, Franz CE, Jacobson KC, Toomey R, Xian H, Vasilopoulos T, Rana BK, McKenzie R, Lyons MJ, Kremen WS (2015). Genetic and environmental architecture of changes in episodic memory from middle to late middle age. Psychol Aging, 30(2), 286-300.
  80. Docherty AR, Bigdeli TB, Edwards AC, Bacanu S, Lee D, Neale MC, Wormley BK, Walsh D, ONeill FA, Riley BP, Kendler KS, Fanous AH (2015). Genome-wide gene pathway analysis of psychotic illness symptom dimensions based on a new schizophrenia-specific model of the OPCRIT. Schizophr Res, 164(1-3), 181-6.
  81. Docherty AR, Sponheim SR, Kerns JG (2015). Self-reported affective traits and current affective experiences of biological relatives of people with schizophrenia. Schizophr Res, 161(2-3), 340-4.
  82. Docherty AR, Hagler DJ Jr, Panizzon MS, Neale MC, Eyler LT, Fennema-Notestine C, Franz CE, Jak A, Lyons MJ, Rinker DA, Thompson WK, Tsuang MT, Dale AM, Kremen WS (2015). Does degree of gyrification underlie the phenotypic and genetic associations between cortical surface area and cognitive ability? Neuroimage, 106, 154-60.
  83. Cicero DC, Docherty AR, Becker TM, Martin EA, Kerns JG (2015). Aberrant salience, self-concept clarity, and interview-rated psychotic-like experiences. J Pers Disord, 29(1), 79-99.
  84. Docherty AR, Sawyers CK, Panizzon MS, Neale MC, Eyler LT, Fennema-Notestine C, Franz CE, Chen CH, McEvoy LK, Verhulst B, Tsuang MT, Kremen WS (2015). Genetic network properties of the human cortex based on regional thickness and surface area measures. Front Hum Neurosci, 9, 440.
  85. Docherty AR, Sponheim SR, Kerns JG (2014). Further examination of ambivalence in relation to the schizophrenia spectrum. Schizophr Res, 158(1-3), 261-3.
  86. Cicero DC, Martin EA, Becker TM, Docherty AR, Kerns JG (2014). Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population. Psychol Assess, 26(3), 901-15.
  87. Docherty AR, Sponheim SR, Gizer IR (2014). DISC1 loci not associated with anhedonia in individuals with genetic liability for schizophrenia. Psychiatr Genet, 24(3), 120-1.
  88. January AM, Meyerson DA, Reddy LF, Docherty AR, Klonoff EA (2014). Impressions of misconduct: Clinical psychology doctoral students’ perceptions of faculty ethical violations. Train Educ Prof Psychol, 8(4), 261-8.
  89. Docherty AR, Cicero DC, Becker TM, Kerns JG (2014). Self-reported ambivalence in schizophrenia and associations with negative mood. J Nerv Ment Dis, 202(1), 70-3.
  90. Eaton NR, Krueger RF, Docherty AR, Sponheim SR (2014). Toward a model-based approach to the clinical assessment of personality psychopathology. J Pers Assess, 96(3), 283-92.
  91. Vrieze SI, Docherty A, Thuras P, Arbisi P, Iacono WG, Sponheim S, Erbes CR, Siegel W, Leskela J (2013). Best practices: The electronic medical record is an invaluable clinical tool: let's start using it. Psychiatr Serv, 64(10), 946-9.
  92. Cicero DC, Becker TM, Martin EA, Docherty AR, Kerns JG (2013). The role of aberrant salience and self-concept clarity in psychotic-like experiences. Personal Disord, 4(1), 33-42.
  93. Docherty AR, Coleman MJ, Tu X, Deutsch CK, Mendell NR, Levy DL (2012). Comparison of putative intermediate phenotypes in schizophrenia patients with and without obsessive-compulsive disorder: examining evidence for the schizo-obsessive subtype. Schizophr Res, 140(1-3), 83-6.
  94. Docherty AR, Berenbaum H, Kerns JG (2011). Alogia and formal thought disorder: differential patterns of verbal fluency task performance. J Psychiatr Res, 45(10), 1352-7.
  95. Martin EA, Becker TM, Cicero DC, Docherty AR, Kerns JG (2011). Differential associations between schizotypy facets and emotion traits. Psychiatry Res, 187(1-2), 94-9.
  96. Docherty AR, Sponheim SR (2008). Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia. J Abnorm Psychol, 117(4), 788-98.
  97. Kerns JG, Docherty AR, Martin EA (2008). Social and physical anhedonia and valence and arousal aspects of emotional experience. J Abnorm Psychol, 117(4), 735-46.
  98. Grijalva FE, Ford JD, Docherty AR, Fricker-Elhai AE, Elhai JD (2008). Sociodemographic associations with mental health and residential care utilization among juvenile delinquents. Psychol Serv, 5(153-60).
  99. Elhai JD, Gray MJ, Docherty AR, Kashdan TB, Kose S (2007). Structural validity of the posttraumatic stress disorder checklist among college students with a trauma history. J Interpers Violence, 22(11), 1471-8.

Book Chapter

  1. Wallace GT, Docherty AR (2020). Emotion Dysregulation and Psychosis Spectrum Disorders. In Theodore P. Beauchaine and Sheila E. Crowell (Eds.), The Oxford Handbook of Emotion Dysregulation. Oxford University Press.
  2. Adkins DE, Rasmussen K, Docherty AR (2019). Social epigenetics of human behavior. In Oxford Handbook of Society and Human Behavior. Oxford UP.
  3. Docherty AR, Sponheim SR (2014). Anhedonia as an Indicator of Genetic Liability to Schizophrenia. In Ritsner M (Ed.), Anhedonia: A Comprehensive Handbook. Dordrecht: Springer.

Letter

  1. Docherty AR (2015). Regarding brain structure characteristics in intellectually superior schizophrenia. [Letter to the editor]. Psychiatry Res, 233(3), 496.

Global Impact

Selected Provider Publications

Journal Article

  1. Lencz T, Sabatello M, Docherty A, Peterson RE, Soda T, Austin J, Bierut L, Crepaz-Keay D, Curtis D, Degenhardt F, Huckins L, Lazaro-Munoz G, Mattheisen M, Meiser B, Peay H, Rietschel M, Walss-Bass C, Davis LK (2022). Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits. Lancet Psychiatry, 9, 838-844.
    Global Impact: Global.

  2. Johnson E, Aliev F, Meyers J, Salvatore JE, Tilman R, Chang Y, Docherty AR, Bogdan R, Acion L, CHan G, Chorlian DB, Kamarajan C, Kuperman S, Pandey A, Plawecki MH, Schuckit M, Tischfield J, Edenberg HJ, Bucholz KK, Nurnberger JI, Porjesz B, Hesselbrock V, Dick DM, Kramer JR, Agrawal A (2021). Associations between suicidal thoughts and behaviors and genetic liability for cognitive performance, depression, and risk-taking in a high-risk sample. Complex Psychiatry, 7(1-2), 34-44.
    Global Impact: Global.

  3. Kim H, Turiano NA, Forbes MK, Kotov R, Krueger RF, Eaton NR, HiTOP Utility Workgroup (2021). Internalizing psychopathology and all-cause mortality: a comparison of transdiagnostic vs. diagnosis-based risk prediction. World Psychiatry, 20(2), 276-282.
    Global Impact: Global.

  4. Krueger RF, Hobbs KA, Conway CC, Dick DM, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Keyes KM, Latzman RD, Michelini G, Patrick CJ, Sellbom M, Slade T, South S, Sunderland M, Tackett J, Waldman I, Waszczuk MA, Wright AG, Zald DH, Watson D, Kotov R the HiTOP Utility Working Group (2020). Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum. . World Psychiatry, 20, 171-193.
    Global Impact: Global.

  5. Kotov R, Jonas KG, Carpenter WT, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Hobbs K, Reininghaus U, Slade T, South SC, Sunderland M, Waszczuk MA, Widiger TA, Wright AGC, Zald DH, Krueger RF, Watson D HiTOP Utility Workgroup (2020). Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum. World Psychiatry, 19(2), 151-172.
    Global Impact: Global.

  6. Johnson EC, Demontis D, Thorgeirsson TE, Walters RK, Polimanti R, Hatoum AS, Sanchez-Roige S, Paul SE, Wendt FR, Clarke TK, Lai D, Reginsson GW, Zhou H, He J, Baranger DAA, Gudbjartsson DF, Wedow R, Adkins DE, Adkins AE, Alexander J, Bacanu SA, Bigdeli TB, Boden J, Brown SA, Bucholz KK, Bybjerg-Grauholm J, Corley RP, Degenhardt L, Dick DM, Domingue BW, Fox L, Goate AM, Gordon SD, Hack LM, Hancock DB, Hartz SM, Hickie IB, Hougaard DM, Krauter K, Lind PA, McClintick JN, McQueen MB, Meyers JL, Montgomery GW, Mors O, Mortensen PB, Nordentoft M, Pearson JF, Peterson RE, Reynolds MD, Rice JP, Runarsdottir V, Saccone NL, Sherva R, Silberg JL, Tarter RE, Tyrfingsson T, Wall TL, Webb BT, Werge T, Wetherill L, Wright MJ, Zellers S, Adams MJ, Bierut LJ, Boardman JD, Copeland WE, Farrer LA, Foroud TM, Gillespie NA, Grucza RA, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono WG, Johnson EO, Kendler KS, Kennedy MA, Kranzler HR, Madden PAF, Maes HH, Maher BS, Martin NG, McGue M, McIntosh AM, Medland SE, Nelson EC, Porjesz B, Riley BP, Stallings MC, Vanyukov MM, Vrieze S Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Davis LK, Bogdan R, Gelernter J, Edenberg HJ, Stefansson K, Brglum AD, Agrawal A (2020). A large-scale genome-wide association study meta-analysis of cannabis use disorder. Lancet Psychiatry.
    Global Impact: Global.

  7. Docherty AR, Shabalin AA, DiBlasi E, Monson E, Mullins N, Adkins DE, Bacanu SA, Bakian AV, Crowell S, Darlington T, Callor W, Christensen E, Gray D, Keeshin B, Klein M, Anderson JS, Jerominski L, Hayward C, Porteous D, McIntosh A, Li Q, Coon H (2020). Genome-wide association analysis of suicide death and polygenic prediction of clinical antecedents. Am J Psychiatry, 177(10), 917-927.
    Global Impact: Global.

  8. Docherty AR, Moscati A, Bigdeli TB, Edwards AC, Peterson RE, Adkins DE, Anderson JS, Flint J, Kendler KS, Bacanu SA (2019). Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE. Psychol Med, 50(5), 793-798.
    Global Impact: China, Global.

  9. Shade J, Coon H, Docherty AR (2019). Ethical implications of using biobanks and population databases for genetic suicide research. Am J Med Genet B Neuropsychiatr Genet, 180(8), 601-608.
    Global Impact: Global.

  10. Lee P, Smoller JDocherty AR, Cross Disorder Working Group of the Psychiatric Genomics Consortium (2019). Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell, 179(7), 1469-1482.
    Global Impact: Africa, China, Europe, Global, South America.

  11. Soda, T, Sullivan, P, ECT Working Group of the Psychiatric Genomics Consortium, Baune, B (2019). A global initiative to investigate the genomics of severe depression and response to electroconvulsive therapy (ECT): The Genomics of ECT international consortium (GenECT-ic). Lancet Psychiatry.
    Global Impact: China, Europe, Korea.

  12. Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, Datta G, Davila-Velderrain J, McGuire D, Tian C, Zhan X, 23andMe Research Team, HUNT All-In Psychiatry, Choquet H, Docherty AR, Faul JD, Foerster JR, Fritsche LG, Gabrielsen ME, Gordon SD, Haessler J, Hottenga JJ, Huang H, Jang SK, Jansen PR, Ling Y, Mgi R, Matoba N, McMahon G, Mulas A, Orr V, Palviainen T, Pandit A, Reginsson GW, Skogholt AH, Smith JA, Taylor AE, Turman C, Willemsen G, Young H, Young KA, Zajac GJM, Zhao W, Zhou W, Bjornsdottir G, Boardman JD, Boehnke M, Boomsma DI, Chen C, Cucca F, Davies GE, Eaton CB, Ehringer MA, Esko T, Fiorillo E, Gillespie NA, Gudbjartsson DF, Haller T, Harris KM, Heath AC, Hewitt JK, Hickie IB, Hokanson JE, Hopfer CJ, Hunter DJ, Iacono WG, Johnson EO, Kamatani Y, Kardia SLR, Keller MC, Kellis M, Kooperberg C, Kraft P, Krauter KS, Laakso M, Lind PA, Loukola A, Lutz SM, Madden PAF, Martin NG, McGue M, McQueen MB, Medland SE, Metspalu A, Mohlke KL, Nielsen JB, Okada Y, Peters U, Polderman TJC, Posthuma D, Reiner AP, Rice JP, Rimm E, Rose RJ, Runarsdottir V, Stallings MC, Stankov A, Stefansson H, Thai KK, Tindle HA, Tyrfingsson T, Wall TL, Weir DR, Weisner C, Whitfield JB, Winsvold BS, Yin J, Zuccolo L, Bierut LJ, Hveem K, Lee JJ, Munaf MR, Saccone NL, Willer CJ, Cornelis MC, David SP, Hinds DA, Jorgenson E, Kaprio J, Stitzel JA, Stefansson K, Thorgeirsson TE, Abecasis G, Liu DJ, Vrieze S (2019). Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet, 51(2), 237-244.
    Global Impact: Global.

  13. Walters RK, Polimanti R, Johnson EC, McClintick JN, Adams MJ, Adkins AE, Aliev F, Bacanu SA, Batzler A, Bertelsen S, Biernacka JM, Bigdeli TB, Chen LS, Clarke TK, Chou YL, Degenhardt F, Docherty AR, Edwards AC, Fontanillas P, Foo JC, Fox L, Frank J, Giegling I, Gordon S, Hack LM, Hartmann AM, Hartz SM, Heilmann-Heimbach S, Herms S, Hodgkinson C, Hoffmann P, Jan Hottenga J, Kennedy MA, Alanne-Kinnunen M, Konte B, Lahti J, Lahti-Pulkkinen M, Lai D, Ligthart L, Loukola A, Maher BS, Mbarek H, McIntosh AM, McQueen MB, Meyers JL, Milaneschi Y, Palviainen T, Pearson JF, Peterson RE, Ripatti S, Ryu E, Saccone NL, Salvatore JE, Sanchez-Roige S, Schwandt M, Sherva R, Streit F, Strohmaier J, Thomas N, Wang JC, Webb BT, Wedow R, Wetherill L, Wills AG, 23andMe Research Team, Boardman JD, Chen D, Choi DS, Copeland WE, Culverhouse RC, Dahmen N, Degenhardt L, Domingue BW, Elson SL, Frye MA, Gbel W, Hayward C, Ising M, Keyes M, Kiefer F, Kramer J, Kuperman S, Lucae S, Lynskey MT, Maier W, Mann K, Mnnist S, Mller-Myhsok B, Murray AD, Nurnberger JI, Palotie A, Preuss U, Rikknen K, Reynolds MD, Ridinger M, Scherbaum N, Schuckit MA, Soyka M, Treutlein J, Witt S, Wodarz N, Zill P, Adkins DE, Boden JM, Boomsma DI, Bierut LJ, Brown SA, Bucholz KK, Cichon S, Costello EJ, de Wit H, Diazgranados N, Dick DM, Eriksson JG, Farrer LA, Foroud TM, Gillespie NA, Goate AM, Goldman D, Grucza RA, Hancock DB, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono W, Johnson EO, Kaprio JA, Karpyak VM, Kendler KS, Kranzler HR, Krauter K, Lichtenstein P, Lind PA, McGue M, MacKillop J, Madden PAF, Maes HH, Magnusson P, Martin NG, Medland SE, Montgomery GW, Nelson EC, Nthen MM, Palmer AA, Pedersen NL, Penninx BWJH, Porjesz B, Rice JP, Rietschel M, Riley BP, Rose R, Rujescu D, Shen PH, Silberg J, Stallings MC, Tarter RE, Vanyukov MM, Vrieze S, Wall TL, Whitfield JB, Zhao H, Neale BM, Gelernter J, Edenberg HJ, Agrawal A (2018). Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat Neurosci, 21(12), 1656-1669.
    Global Impact: Global.

  14. Edwards AC, Aggen SH, Cai N, Bigdeli TB, Peterson RE, Docherty AR, Webb BT, Bacanu SA, Flint J, Kendler KS (2016). Chronicity of depression and molecular markers in a large sample of Han Chinese women. Depress Anxiety, 33(11), 1048-1054.
    Global Impact: China.

Presentations

Docherty, A. R., Cohen, A., Debbian, M., Adkins, D. E., & Chan, R. (2017). Psychiatric Genomics and Schizotypy: An Organizing Framework. Symposium presented at the annual meeting of the International Schizotypy Consortium, Beijing, China. Global

Service

04/01/2022 Chair Suicide Working Group Global
01/01/2022 Chair Ethics, Position, & Public Policy Committee Global
09/01/2018 Member & Advisor Genomic Testing Advisory Committee Global
01/01/2018 Advisory Committee Member Ethics Committee Global
03/01/2017 Scientific Abstract Reviewer Early Career Investigator Award Committee Global
04/01/2016 Symposium Reviewer Symposium Award Committee Global

News Articles

How do mental health conditions affect the LGBTQIA+ community? 

Vitae 2020: People and Stories that Drive Our Research

Genetic Discovery Could Lead to Better Prediction of Suicide Risk Within Families

The Scope & Other Podcasts

  • Leveraging (the new) Psychiatric Genomics for a Healthier Utah
  • Modeling the Dimensionality & the Genetic Heterogeneity of Psychopathology

Videos

Modeling the Dimensionality & the Genetic Heterogeneity of Psychopathology

Leveraging (the new) Psychiatric Genomics for a Healthier Utah

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health